Package | dk.kip.rkkp.fhir.ig.core |
Type | CodeSystem |
Id | TreatmentRegimen |
FHIR Version | R4 |
Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/CodeSystem-TreatmentRegimen.html |
URL | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen |
Version | 2.12.0 |
Status | active |
Date | 2022-07-12T00:00:00+02:00 |
Name | TreatmentRegimen |
Title | Treatment regimen |
Description | Treatment regimen |
Content | complete |
ValueSet | |
TreatmentRegimen | Behandlingsplan |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem TreatmentRegimen
This case-insensitive code system https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen
defines the following codes:
{ "resourceType": "CodeSystem", "id": "TreatmentRegimen", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen", "version": "2.12.0", "name": "TreatmentRegimen", "title": "Treatment regimen", "status": "active", "date": "2022-07-12T00:00:00+02:00", "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact": [ { "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom": [ { "system": "url", "value": "https://trifork.com" }, { "system": "email", "value": "rbk@trifork.com" } ] } ], "description": "Treatment regimen", "caseSensitive": false, "content": "complete", "count": 37, "concept": [ { "code": "toplusfem", "display": "2+5 eller lign, eks. CT", "definition": "2+5 eller lign, eks. CT" }, { "code": "aida", "display": "AIDA", "definition": "AIDA" }, { "code": "all_ved", "display": "ALL vedligehold", "definition": "ALL vedligehold" }, { "code": "atoatra", "display": "ATO+ATRA", "definition": "ATO+ATRA" }, { "code": "azacitidinmono", "display": "Azacitidin monoterapi", "definition": "Azacitidin monoterapi" }, { "code": "azacitidinvene", "display": "Azacitidin-venetoclax", "definition": "Azacitidin-venetoclax" }, { "code": "hydrea", "display": "Hydrea", "definition": "Hydrea" }, { "code": "hdara_c", "display": "Hd-Ara-c +- supplement", "definition": "Hd-Ara-c +- supplement" }, { "code": "ade", "display": "ADE +- supplement", "definition": "ADE +- supplement" }, { "code": "da", "display": "DA +- supplement", "definition": "DA +- supplement" }, { "code": "da31087", "display": "DA inkl. 3+10, 3+8, 3+7", "definition": "DA inkl. 3+10, 3+8, 3+7" }, { "code": "da31087my", "display": "DA inkl. 3+10, 3+8, 3+7 + mylotarg", "definition": "DA inkl. 3+10, 3+8, 3+7 + mylotarg" }, { "code": "da31087mi", "display": "DA inkl. 3+10, 3+8, 3+7 + midostaurin", "definition": "DA inkl. 3+10, 3+8, 3+7 + midostaurin" }, { "code": "flag", "display": "FLAG +- supplement", "definition": "FLAG +- supplement" }, { "code": "flagmito", "display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG", "definition": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG" }, { "code": "flagmitovene", "display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax", "definition": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax" }, { "code": "gilteritinib", "display": "Gilteritinib", "definition": "Gilteritinib" }, { "code": "idarac", "display": "IdAraC", "definition": "IdAraC" }, { "code": "inotuzumab", "display": "Inotuzumab ozogamicin", "definition": "Inotuzumab ozogamicin" }, { "code": "mace", "display": "MACE +- supplement", "definition": "MACE +- supplement" }, { "code": "midac", "display": "MidAC", "definition": "MidAC" }, { "code": "midostaurin_ved", "display": "Midostaurin vedligehold", "definition": "Midostaurin vedligehold" }, { "code": "ldara", "display": "LdARA-C +- supplement", "definition": "LdARA-C +- supplement" }, { "code": "atra", "display": "ATRA", "definition": "ATRA" }, { "code": "apl_mt", "display": "APL-vedligeholdsbehandling", "definition": "APL-vedligeholdsbehandling" }, { "code": "azacytidin_supplement", "display": "5-Azacytidin +- supplement", "definition": "5-Azacytidin +- supplement" }, { "code": "blinatumomab", "display": "Blinatumomab", "definition": "Blinatumomab" }, { "code": "vyxeos", "display": "Vyxeos +- supplement", "definition": "Vyxeos +- supplement" }, { "code": "nopho_2008", "display": "NOPHO-2008", "definition": "NOPHO-2008" }, { "code": "all_mt", "display": "ALL vedligeholdelsesbehandling", "definition": "ALL vedligeholdelsesbehandling" }, { "code": "other_ikke", "display": "Anden ikke-intensiv", "definition": "Anden ikke-intensiv" }, { "code": "other_eks", "display": "Anden eksperimentel", "definition": "Anden eksperimentel" }, { "code": "other_semi", "display": "Anden semiintensiv (f.eks. Plan B)", "definition": "Anden semiintensiv (f.eks. Plan B)" }, { "code": "other_int", "display": "Anden intensiv (f.eks. BISHOP, Plan A)", "definition": "Anden intensiv (f.eks. BISHOP, Plan A)" }, { "code": "hyper_cvad", "display": "Hyper-CVAD", "definition": "Hyper-CVAD" }, { "code": "alltogether_mt", "display": "ALLtogether", "definition": "ALLtogether" }, { "code": "experimental", "display": "anden behl incl anden experimentel", "definition": "anden behl incl anden experimentel" } ] }